A systematic review of individual and community mitigation measures for prevention and control of chikungunya virus.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 27 09 2018
accepted: 15 01 2019
entrez: 28 2 2019
pubmed: 28 2 2019
medline: 8 11 2019
Statut: epublish

Résumé

Chikungunya is a mosquito-borne virus transmitted by mosquitoes from the Aedes genus. The virus, endemic to parts of Asia and Africa, has recently undergone an emergence in other parts of the world where it was previously not found including Indian Ocean Islands, Europe, the Western Pacific and the Americas. There is no vaccine against chikungunya virus, which means that prevention and mitigation rely on personal protective measures and community level interventions including vector control. A systematic review (SR) was conducted to summarize the literature on individual and community mitigation and control measures and their effectiveness. From a scoping review of the global literature on chikungunya, there were 91 articles that investigated mitigation or control strategies identified at the individual or community level. Of these, 81 were confirmed as relevant and included in this SR. The majority of the research was published since 2010 (76.5%) and was conducted in Asia (39.5%). Cross sectional studies were the most common study design (36.6%). Mitigation measures were placed into six categories: behavioural protective measures, insecticide use, public education, control of blood and blood products, biological vector control and quarantine of infected individuals. The effectiveness of various mitigation measures was rarely evaluated and outcomes were rarely quantitative, making it difficult to summarize results across studies and between mitigation strategies. Meta-analysis of the proportion of individuals engaging in various mitigation measures indicates habitat removal is the most common measure used, which may demonstrate the effectiveness of public education campaigns aimed at reducing standing water. Further research with appropriate and consistent outcome measurements are required in order to determine which mitigation measures, or combination of mitigation measures, are the most effective at protecting against exposure to chikungunya virus.

Sections du résumé

BACKGROUND
Chikungunya is a mosquito-borne virus transmitted by mosquitoes from the Aedes genus. The virus, endemic to parts of Asia and Africa, has recently undergone an emergence in other parts of the world where it was previously not found including Indian Ocean Islands, Europe, the Western Pacific and the Americas. There is no vaccine against chikungunya virus, which means that prevention and mitigation rely on personal protective measures and community level interventions including vector control.
METHODOLOGY/PRINCIPAL FINDINGS
A systematic review (SR) was conducted to summarize the literature on individual and community mitigation and control measures and their effectiveness. From a scoping review of the global literature on chikungunya, there were 91 articles that investigated mitigation or control strategies identified at the individual or community level. Of these, 81 were confirmed as relevant and included in this SR. The majority of the research was published since 2010 (76.5%) and was conducted in Asia (39.5%). Cross sectional studies were the most common study design (36.6%). Mitigation measures were placed into six categories: behavioural protective measures, insecticide use, public education, control of blood and blood products, biological vector control and quarantine of infected individuals. The effectiveness of various mitigation measures was rarely evaluated and outcomes were rarely quantitative, making it difficult to summarize results across studies and between mitigation strategies. Meta-analysis of the proportion of individuals engaging in various mitigation measures indicates habitat removal is the most common measure used, which may demonstrate the effectiveness of public education campaigns aimed at reducing standing water.
CONCLUSIONS/SIGNIFICANCE
Further research with appropriate and consistent outcome measurements are required in order to determine which mitigation measures, or combination of mitigation measures, are the most effective at protecting against exposure to chikungunya virus.

Identifiants

pubmed: 30811438
doi: 10.1371/journal.pone.0212054
pii: PONE-D-18-28292
pmc: PMC6392276
doi:

Substances chimiques

Insecticides 0

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0212054

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Virol. 2014 Jun;88(11):6294-306
pubmed: 24672026
J Eval Clin Pract. 2008 Oct;14(5):941-50
pubmed: 19018929
Euro Surveill. 2016 Sep 8;21(36):
pubmed: 27631156
PLoS Negl Trop Dis. 2014 Jan 02;8(1):e2609
pubmed: 24392170
Pathog Glob Health. 2014 Mar;108(2):76-94
pubmed: 24649867
J Environ Health. 2012 Jan-Feb;74(6):8-13; quiz 64
pubmed: 22329203
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
J Clin Diagn Res. 2013 Jun;7(6):1059-62
pubmed: 23905103
Can J Infect Dis Med Microbiol. 2016;2016:2980297
pubmed: 27366163
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Indian J Med Res. 2015 Dec;142 Suppl:S108-10
pubmed: 26905235
J Virol. 2014 Oct;88(20):11644-7
pubmed: 25078691
J Gen Virol. 2007 Sep;88(Pt 9):2363-77
pubmed: 17698645
Math Biosci Eng. 2012 Apr;9(2):369-92
pubmed: 22901069
PLoS One. 2011 May 03;6(5):e18860
pubmed: 21559329
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Biomed Res Int. 2014;2014:746509
pubmed: 24822216
Emerg Infect Dis. 2015 May;21(5):909-11
pubmed: 25898214
Lancet. 2007 Dec 1;370(9602):1840-6
pubmed: 18061059
West J Emerg Med. 2014 Nov;15(7):841-4
pubmed: 25493131
J Commun Dis. 2011 Sep;43(3):209-15
pubmed: 23781634
Int J Health Sci (Qassim). 2007 Jul;1(2):303-8
pubmed: 21475442
PLoS Negl Trop Dis. 2017 Sep 11;11(9):e0005918
pubmed: 28892499
Am J Trop Med Hyg. 2010 Mar;82(3):508-11
pubmed: 20207883
Travel Med Infect Dis. 2016 Jan-Feb;14(1):26-31
pubmed: 26869532
Emerg Infect Dis. 2006 Dec;12(12):1994-5
pubmed: 17354339
J Miss State Med Assoc. 2016 May;57(5):138-41
pubmed: 27386666
Transfusion. 2014 Aug;54(8):1945-52
pubmed: 24527811
J Glob Infect Dis. 2011 Jan;3(1):32-6
pubmed: 21572606
PLoS Med. 2006 Jul;3(7):e263
pubmed: 16700631
Trans R Soc Trop Med Hyg. 2013 Nov;107(11):706-14
pubmed: 24114673
Vox Sang. 2013 Jan;104(1):12-8
pubmed: 22775433
PLoS Negl Trop Dis. 2013;7(3):e2137
pubmed: 23556021
Emerg Infect Dis. 2015 Aug;21(8):1409-13
pubmed: 26196378
Indian J Community Med. 2011 Apr;36(2):124-7
pubmed: 21976797
Ann Med Health Sci Res. 2014 Mar;4(2):227-32
pubmed: 24761243
PLoS One. 2013;8(3):e59716
pubmed: 23527259
PLoS One. 2018 Nov 29;13(11):e0207554
pubmed: 30496207
Math Biosci Eng. 2010 Apr;7(2):313-45
pubmed: 20462292
MMWR Morb Mortal Wkly Rep. 2016 May 13;65(18):479-80
pubmed: 27171600
Transfusion. 2016 Jun;56(6 Pt 2):1548-55
pubmed: 26926832
Salud Publica Mex. 2016 Aug;58(4):472-5
pubmed: 27599081
Acta Trop. 2012 Aug;123(2):85-90
pubmed: 22525433
PLoS Negl Trop Dis. 2016 Nov 1;10(11):e0005081
pubmed: 27802275
Epidemiol Infect. 2008 Feb;136(2):196-206
pubmed: 17433130
Western Pac Surveill Response J. 2013 Mar 18;4(1):46-50
pubmed: 23908956
Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):13420-13425
pubmed: 27821727
Emerg Infect Dis. 2011 Feb;17(2):309-11
pubmed: 21291616
J Travel Med. 2016 Jul 04;23(5):
pubmed: 27378367
Emerg Infect Dis. 2014 Oct;20(10):1773-4
pubmed: 25271852
Emerg Infect Dis. 2011 May;17(5):910-3
pubmed: 21529410
Commun Dis Intell Q Rep. 2014 Jun 30;38(2):E122-42
pubmed: 25222207
Am J Trop Med Hyg. 2016 Jun 1;94(6):1336-41
pubmed: 26976891
Pediatr Infect Dis J. 2007 Sep;26(9):811-5
pubmed: 17721376
Health Place. 2009 Sep;15(3):659-69
pubmed: 19121600
Transfusion. 2016 Aug;56(8):2100-7
pubmed: 27362275
Int J Environ Res Public Health. 2011 May;8(5):1358-67
pubmed: 21655124
Am J Trop Med Hyg. 2007 Oct;77(4):727-31
pubmed: 17978079
PLoS One. 2014 Sep 25;9(9):e108504
pubmed: 25255027
J Infect Dev Ctries. 2015 Mar 15;9(3):330-2
pubmed: 25771475
PLoS Negl Trop Dis. 2016 Jun 20;10(6):e0004773
pubmed: 27322692
Sci Rep. 2016 Apr 05;6:23997
pubmed: 27045523
Natl Med J India. 2010 Mar-Apr;23(2):82-4
pubmed: 20925203
Health Policy. 2007 Oct;83(2-3):196-212
pubmed: 17316882
Malar J. 2011 Aug 04;10:225
pubmed: 21816085
Environ Health Perspect. 2017 Apr;125(4):579-585
pubmed: 27713106
PLoS Negl Trop Dis. 2016 Apr 26;10(4):e0004664
pubmed: 27115737
BMC Public Health. 2011 Jul 28;11:599
pubmed: 21798018
Vector Borne Zoonotic Dis. 2016 Jan;16(1):58-60
pubmed: 26741323
Blood Transfus. 2008 Oct;6(4):199-210
pubmed: 19112735
PLoS One. 2014 Mar 17;9(3):e91170
pubmed: 24637507
Southeast Asian J Trop Med Public Health. 1975 Dec;6(4):580-91
pubmed: 131977
PLoS Negl Trop Dis. 2016 Apr 15;10(4):e0004625
pubmed: 27082985
Clin Microbiol Infect. 2010 Dec;16(12):1702-4
pubmed: 21040155
BMJ Open. 2012 Nov 28;2(6):
pubmed: 23194955
Blood. 2014 Jun 5;123(23):3679-81
pubmed: 24904107
Pathog Glob Health. 2016 Mar;110(2):68-73
pubmed: 27159571
Euro Surveill. 2014 Apr 03;19(13):
pubmed: 24721539
PLoS One. 2012;7(8):e42830
pubmed: 22916166
Environ Health Perspect. 2012 Apr;120(4):577-82
pubmed: 22251458
Emerg Infect Dis. 2009 May;15(5):836-7
pubmed: 19402989
Trans R Soc Trop Med Hyg. 2008 Dec;102(12):1247-54
pubmed: 18502458
J Infect. 2011 Apr;62(4):263-70
pubmed: 21315108
Antiviral Res. 2013 Sep;99(3):345-70
pubmed: 23811281
Neurology. 2016 Jan 5;86(1):94-102
pubmed: 26609145
Parassitologia. 2008 Jun;50(1-2):97-8
pubmed: 18693568
PLoS Negl Trop Dis. 2016 Oct 20;10(10):e0005075
pubmed: 27764085
Singapore Med J. 2012 Apr;53(4):e66-8
pubmed: 22511064
J R Soc Interface. 2012 Oct 7;9(75):2708-17
pubmed: 22535696
PLoS Negl Trop Dis. 2016 Dec 1;10(12):e0005109
pubmed: 27906987
Med Trop (Mars). 2012 Mar;72 Spec No:66-71
pubmed: 22693932
Euro Surveill. 2015 Apr 30;20(17):
pubmed: 25955774
Travel Med Infect Dis. 2016 Sep - Oct;14(5):475-480
pubmed: 27597388
Parassitologia. 2001 Jun;43(1-2):1-89
pubmed: 11921521
Trans R Soc Trop Med Hyg. 2009 Feb;103(2):192-6
pubmed: 18930301
Emerg Infect Dis. 2006 Jun;12(6):887-93
pubmed: 16707042

Auteurs

Catherine Hierlihy (C)

Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Guelph, Ontario, Canada.
Department of Population Medicine, University of Guelph, Guelph, Ontario, Canada.

Lisa Waddell (L)

Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Guelph, Ontario, Canada.

Ian Young (I)

School of Occupational and Public Health, Ryerson University, Toronto, Ontario, Canada.

Judy Greig (J)

Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Guelph, Ontario, Canada.

Tricia Corrin (T)

Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Guelph, Ontario, Canada.
Department of Population Medicine, University of Guelph, Guelph, Ontario, Canada.

Mariola Mascarenhas (M)

Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Guelph, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH